Avenir™ is a carrier screening test that determines if you and/or your partner carry a potentially disease-causing genetic mutation that could be passed on to your future child. Your results can help you evaluate your risk of having a child with a genetic condition.
Previda™ is a preimplantation genetic screening (PGS) test that evaluates chromosome copy in an embryo biopsy. The goal of Previda-PGS is to increase the chance of implantation and reduce the risk of miscarriage.
Previda™-DX is a preimplantation genetic diagnosis (PGD) test that detects potentially disease-causing mutations in an embryo biopsy. The test is customized to your personal genetic background to help you conceive a healthy baby.
MitoSure provides an estimate of the amount of mitochondrial DNA present in an embryo relative to nuclear DNA. An abnormally high MitoSure score may be detrimental to an embryo’s implantation potential.
Novelvi is a non-invasive prenatal test (NIPT) that offers screens the developing fetus for major chromosomal abnormalities. Patients may also opt for an expanded panel that includes all 23 pair of chromosomes as well as clinically significant microdeletions.
Revela™ is a secure online patient management system to support our genetic testing products. With Revela™, medical practices are able to reduce paperwork, increase efficiency, and access test status or results in real-time.
At Progenesis, we are fully dedicated to our clients. Our services are highly customized to each patient’s individual needs.